Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism.
Palese F, Pontis S, Realini N, Torrens A, Ahmed F, Assogna F, Pellicano C, Bossù P, Spalletta G, Green K, et al. Pharmacol Res. 2022 Aug; 182:106338. Epub 2022 Jun 30.